Tag: Bristol
Bristol Myers: New Data in Psoriasis
(CercleFinance.com) – Bristol Myers Squibb announces new long-term data on Sotyktu TM (deucravacitinib) showing sustained clinical efficacy for up to two years in case of continuous treatment in moderate to…
Bristol Myers: Failure of a phase 3 trial for cancer
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…